EP
TNDM icon

Eversept Partners’s Tandem Diabetes Care TNDM Stock Holding History

Eversept Partners’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-256,268
Closed -$15.2M – 85
2022
Q2 		$15.2M Buy
+256,268
New +$21M 1.08% 29
2018
Q3 		– Sell
-61,300
Closed -$1.35M – 72
2018
Q2 		$1.35M Buy
+61,300
New +$754K 0.62% 34

Other funds holding TNDM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
EC
Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Eversept Partners's TNDM Position: Q3 2022 in Review

Eversept Partners sold out of Tandem Diabetes Care (TNDM) in Q3 2022, closing a stake of 256,268 shares — an estimated $15.2M sold.

Eversept Partners first reported a position in TNDM in Q2 2018 and held it in 2 quarters. The position peaked at $15.2M in Q2 2022. 299 funds tracked by Wall St. Rank hold TNDM as of Q3 2022.

  • Eversept Partners reported no remaining Tandem Diabetes Care position as of Q3 2022 after selling out during the quarter.
  • Eversept Partners sold 256,268 Tandem Diabetes Care shares in Q3 2022, an estimated $15.2M.
  • Eversept Partners first reported a position in Tandem Diabetes Care in Q2 2018 and held it in 2 quarters.
  • Eversept Partners's Tandem Diabetes Care position peaked at $15.2M in Q2 2022.
  • 299 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2022.

Based on Eversept Partners's 13F filing for Q3 2022, filed 14 Nov 2022.